Accucinch
Payments companies reported to CMS as associated with Accucinch. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Accucinch, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Accucinch
These are the largest totals companies reported as associated with Accucinch. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ulrich Jorde | New York, NY | Cardiovascular Disease | $71,752.09 |
| David Lim | Stockton, CA | Cardiovascular Disease | $42,150.00 |
| Gregg Stone | New York, NY | Cardiovascular Disease | $36,371.38 |
| Mark Reisman | New York, NY | Interventional Cardiology | $25,933.47 |
| Sean Pinney | New York, NY | Advanced Heart Failure and Transplant Cardiology | $23,866.30 |
| Harsh Golwala | Portland, OR | Interventional Cardiology | $11,139.50 |
| Dominick Bufalino | Downers Grove, IL | Interventional Cardiology | $10,947.50 |
| Martin Leon | New York, NY | Interventional Cardiology | $7,372.03 |
| Jason Foerst | Roanoke, VA | Interventional Cardiology | $7,233.51 |
| Rohit Amin | Pensacola, FL | Interventional Cardiology | $5,405.59 |
Prescribed Accucinch?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.